Trump scraps Biden's plan to cover Wegovy and Zepbound through MedicareTrump administration's decision excludes expensive obesity treatments from Medicare coverage.
Home medical devices pose risks for Medicare beneficiaries and their caregiversHome medical devices offer health assistance but present potential safety issues and lack comprehensive support for users.
Ozempic and Wegovy should be covered by Medicare as weight loss treatments: KFF pollGLP-1 drugs used for diabetes and heart disease gaining popularity as weight loss treatments.KFF survey shows limited usage of GLP-1 drugs for weight loss, with interest in Medicare coverage for weight loss drugs.
Does Medicare pay for dementia care? Here's what coverage you can expect for treatments and therapiesDementia is not a normal part of aging, while age-related memory loss is common.